Skip to main content

Table 1 Associations between RBM3 and PODXL expression and clinicopathological characteristics

From: Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study

PODXL Expression (n = 262) RBM3 expression (n = 259)
  Non-membranous Membranous   Low (NS = 0–4) High (NS = 6–9)  
N (%) 235 (89.7%) 27 (10.3%) p-value 104 (40.2%) 155 (59.8%) p-value
Age
 Mean/median 71.4/71.4 71.2/72.4 0.933 72.2/72.5 70.6/70.5 0.069
 Range 51.2–86.6 56.2–86.8   51.3–86.8 51.2–86.6  
Sex
 Female 67 (84.8%) 12 (15.2%) 0.088 32 (40.0%) 48 (60.0%) 0.973
 Male 168 (91.8%) 15 (8.2%)   72 (40.2%) 107 (59.8%)  
T-stage
 Ta 113 (100.0%) 0 (0.0%) <0.001 30 (26.3%) 84 (73.7%) <0.001
 T1 73 (88.0%) 10 (12.0%)   28 (34.6%) 53 (65.4%)  
 T2–4 49 (74.2%) 17 (25.8%)   46 (71.9%) 18 (28.1%)  
Grade
 Low 128 (99.2%) 1 (0.8%) <0.001 27 (20.8%) 103 (79.2%) <0.001
 High 107 (80.5%) 26 (19.5%)   77 (59.7%) 52 (40.3%)  
\